Clinical Trial

Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
a randomized, investigator-blind, interventinal study will compare the effect of benzalkonium-chloride (BAK) preserved and preservative-free (PF) eye drops on conjunctival goblet cells.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-06-30; most recent amendment 2023-11-15.
Status change: Not Yet Recruiting → Recruiting 2022-10-25
Trial Details
NCT Number NCT04957329
Lead Sponsor Rigshospitalet, Denmark
Collaborators: Laboratoires Thea
Conditions Glaucoma, Ocular Hypertension
Enrollment 28 participants
Start Date 2021-09-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-11-18